References
- Cleary JF. Cancer pain management. Cancer Control 2000;7:120–31
- Jacox A, Carr DB, Payne R. Management of cancer pain. Clinical Practice Guideline Number 9. Rockville: AHCPR, 1994
- Portenoy RK, Lesage P. Management of cancer pain. Lancet 1999;353:1695–700
- Ahmedzai S, Brooks D. Transdermal fentanyl versus sustained-release oral morphine in cancer pain: preference, efficacy, and quality of life. The TTS-Fentanyl Comparative Trial Group. J Pain Symptom Manage 1997;13:254–61
- Hunt R, Fazekas B, Thorne D, Brooksbank M. A comparison of subcutaneous morphine and fentanyl in hospice cancer patients. J Pain Symptom Manage 1999;18:111–19
- Payne R. Factors influencing quality of life in cancer patients: the role of transdermal fentanyl in the management of pain. Semin Oncol 1998;25:47–53
- Southam MA. Transdermal fentanyl therapy: system design, pharmacokinetics and efficacy. Anticancer Drugs 1995;6 Suppl 3:29–34
- Donner B, Zenz M, Strumpf M, Raber M. Long-term treatment of cancer pain with transdermal fentanyl. J Pain Symptom Manage 1998;15:168–75
- Simmonds MA, Richenbacher J. Transdermal fentanyl: long-term analgesic studies. J Pain Symptom Manage 1992;7:S36–9
- Sloan PA, Moulin DE, Hays H. A clinical evaluation of transdermal therapeutic system fentanyl for the treatment of cancer pain. J Pain Symptom Manage 1998;16:102–11
- Zech DF, Grond SU, Lynch J, Dauer HG, Stollenwerk B, Lehmann KA. Transdermal fentanyl and initial dose-finding with patient-controlled analgesia in cancer pain. A pilot study with 20 terminally ill cancer patients. Pain 1992;50:293–301
- Payne R, Mathias SD, Pasta DJ, Wanke LA, Williams R, Mahmoud R. Quality of life and cancer pain: satisfaction and side-effects with transdermal fentanyl versus oral morphine. J Clin Oncol 1998;16:1588–93
- Jeal W, Benfield P. Transdermal fentanyl. A review of its pharmacological properties and therapeutic efficacy in pain control. Drugs 1997;53:109–38
- Iconomou G, Viha A, Vagenakis AG, Kalofonos HP. Transdermal fentanyl in cancer patients with moderate-to-severe pain: a prospective examination. Anticancer Res 2000;20:4821–4
- Radbruch L, Sabatowski R, Loick G, Kulbe C, Kasper M, Grond S et al. Constipation and the use of laxatives: a comparison between transdermal fentanyl and oral morphine. Palliat Med 2000;14:111–9
- Breitbart W, Chandler S, Eagel B, Ellison N, Enck RE, Lefkowitz M, Payne R. An alternative algorithm for dosing transdermal fentanyl for cancer-related pain. Oncology (Huntingt) 2000;14:695–705
- Jakobsson M, Strang P. Fentanyl patches for the treatment of pain in dying cancer patients. Anticancer Res 1999;19:4441–2
- Vielvoye-Kerkmeer AP, Mattern C, Uitendaal MP. Transdermal fentanyl in opioid-naive cancer pain patients: an open trial using transdermal fentanyl for the treatment of chronic cancer pain in opioid-naive patients and a group using codeine. J Pain Symptom Manage 2000;19:185–92